| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 12.816 | 1.899.904 | 1.766.383 | 1.433.499 |
| Total Income - EUR | - | - | - | - | - | - | 116.091 | 2.265.458 | 2.752.495 | 1.938.986 |
| Total Expenses - EUR | - | - | - | - | - | - | 112.679 | 2.103.693 | 2.279.273 | 1.922.721 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 3.412 | 161.765 | 473.222 | 16.265 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 3.284 | 147.423 | 404.228 | 15.485 |
| Employees | - | - | - | - | - | - | 1 | 5 | 7 | 6 |
Check the financial reports for the company - Biofarms Laboratory S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 48.655 | 231.994 | 230.705 | 229.684 |
| Current Assets | - | - | - | - | - | - | 131.940 | 1.202.312 | 1.009.525 | 1.684.171 |
| Inventories | - | - | - | - | - | - | 99.247 | 395.226 | 110.405 | 353.741 |
| Receivables | - | - | - | - | - | - | 31.897 | 790.461 | 292.228 | 1.212.424 |
| Cash | - | - | - | - | - | - | 796 | 16.625 | 606.892 | 118.006 |
| Shareholders Funds | - | - | - | - | - | - | 3.324 | 150.758 | 449.403 | 462.376 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 177.271 | 1.284.019 | 793.437 | 1.452.689 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "146 - 146" | |||||||||
| CAEN Financial Year |
146
|
|||||||||
Comments - Biofarms Laboratory S.r.l.